Background : Supratentorial diffuse low-grade gliomas in adults extend beyond maximal visible MRI-defined abnormalities, and a gap exists between the imaging signal changes and the actual tumor margins. Direct quantitative comparisons between imaging and histological analyses are lacking to date. However, they are of the utmost importance if one wishes to develop realistic models for diffuse glioma growth.
Introduction
Diffuse gliomas are the most common primary brain tumors in adults. Diffuse low-grade gliomas (DLGG) (World Health Organization grade II gliomas [1] ) share better outcomes than high-grade gliomas [2, 3, 4] . Despite refinements in imaging techniques and therapeutic management, DLGG remain incurable. Tumor invasiveness, particularly tumor cell proliferation and migration, thwarts the efficacy of oncological treatments. With magnetic resonance imaging (MRI), DLGG usually appear as non-contrast enhancing masses of hypointensity with T1-and of hyperintensity with T2-weighted and Fluid Attenuation Inversion Recovery (FLAIR) sequences [5, 6] . Since T2-weighted and FLAIR sequences have a high sensitivity to changes in water content of tissues, the hypersignal in such sequences is generally assumed to reflect the edema that surrounds tumor cells [7, 8, 9] . Conventional MRI underestimates the spatial extent of diffuse gliomas [10, 11, 12, 13] , and we previously showed that conventional MRI underestimates the actual spatial extent of DLGG by identifying isolated tumor cells lying some centimeters beyond imaging abnormalities with T2-weighted and FLAIR sequences in DLGG [14] . The existence of such isolated tumor cells explains: 1) recurrences at the resection margins after gross total surgical removal [15] ; 2) the prognostic significance of the extent of resection [16, 15, 17] ; and 3) the fact that functionalbased resections encompassing a margin beyond MRI-defined abnormalities improves the outcome of DLGG [18] .
Modeling is an alternative way to estimate the actual spatial DLGG extent. A diffusionproliferation partial differential equation has been proposed to model: 1) the evolution of the cell concentration in diffuse gliomas [19, 20] ; 2) oncological treatment efficacy [21, 22, 23, 24, 25] ; and 3) the date of birth of DLGG [26] . This model explains tumor recurrences as the consequence of the diffusion of tumor cells into the surrounding tissue, the density of these tumor cells being below the visibility threshold of MRI, including T2-weighted sequence.
This model is based upon the assumption that MR signal changes are linked to tumor cell concentration, and thus MR signal changes should correspond to a cell concentration threshold [24] . This threshold has been measured once for a glioblastoma by CT-scan [22] , but not by MRI and not for DLGG. A better understanding of the differences between MRIdefined abnormalities and the spatial extent of DLGG is mandatory in order to optimize therapeutic management and to develop models closer to the biological reality. The aim of the present study is to characterize quantitatively the histopathological abnormalities (cell concentration, edema) and to compare them with the imaging abnormalities. We analyzed biopsy samples (BSs) from serial MRI-based stereotactic biopsies performed within and beyond MRI-defined abnormalities in DLGG.
Material and methods

Data selection
We searched the database of a previously published study performed in our institution [14] and focused on patients for whom a low-grade oligodendroglioma was newly diagnosed by MRI-based serial stereotactic biopsies according to the Talairach stereotactic method between January 1992 and December 2001. Inclusion criteria were: 1) absence of oncological treatment prior to stereotactic biopsy; 2) supratentorial hemispheric location; 3) well delineated hypersignal on T2-weighted sequences; 4) absence of contrast enhancement [5] ; 5) less than three-week interval between preoperative MRI and the stereotactic biopsy procedure; 6) biopsy samplings extending beyond MRI-defined abnormalities; and 7) available data for subsequent imaging and pathological analyses. These patients gave their informed consent for storage of the surgical samples for further analyses. We retrospectively selected nine cases of untreated adult patients (median age: 39 years, range 29-54 years) with a newly diagnosed DLGG by between June 1993 and September 2000. Clinical and imaging characteristics of tumors are presented in Table 1 . We analyzed 44 BSs (median, 5; range, 3-8 per patient).
Histological and immunostaining techniques
The BSs were fixed in formalin-zinc (formalin 5%, zinc 3 g/L, sodium chloride 8 g/L) and individually embedded in paraffin. Serial sections were cut at 6 µm. Sections used for immunohistochemistry were microwaved in citrate buffer (pH=6) for antigen retrieval (Micro 
Digitization of the biopsy sample slices
All BSs slices were scanned and digitized with the same microscope (Hamamatsu NanoZoomer C9600-12), at several magnifications. The images have a resolution of 4.4 pixels/µm at the highest magnification (40x). The digitized images were subsequently analyzed using the free software ImageJ (version 1.43).
Fixing the limits of the MRI-defined abnormalities
The MRI-defined abnormalities were estimated using T2-weighted sequence. Possible sources of variability were the manual determination of the limits and the manual choice of the signal window, therefore, the definition of the MRI-defined abnormalities based only on the absolute gray levels would not be reproducible. To solve these problems, we used the following method: 1) we plotted the gray levels of the MRI along the biopsy trajectory; 2) we manually selected the part of the trajectory located inside the cortex, and we calculated the average gray level corresponding to the cortex signal ( Figure 1) ; and 3) we defined the limit of the signal abnormality along the biopsy trajectory as the position where the gray levels drops below the average gray level of cortex.
To ensure the independence between the limits defined as explained above and the initial signal window, we applied this method on a series of images obtained through simulation with different signal windows ( Figure 2 ). In this simulation, the MRIdefined abnormality with T2-weighted sequence of the tumor-brain system is assumed to be the sum of the contribution of the tumor, of the white matter, of the cortex, and of the cerebrospinal fluid. The whole system is discretized as a 100x100 matrix 0 ≤ x ≤ 100, 0 ≤ y ≤ 100. The tumor's contribution is modeled by a Gaussian function,
) . The contribution of the white matter is modeled by a white noise of small amplitude, equal to z=10 (it can be seen in figure 2 . In all three pictures, even though the contrast between white and gray matter changes greatly, the abnormality limit according to our procedure remained the same centered circle with diameter 26.5 ± 1 pixels.
For each patient, the MRI-defined abnormalities defined with this method were validated independently by a senior neurosurgeon (JP).
Imaging and pathological spatial correlation
For the purpose of the present study, we have reassessed the position of each BS with respect to MRI-defined abnormalities using images performed for clinical use. The position of a BS was obtained by reassessing its position in space using a superimposition of intraoperative teleradiographic x-ray images and preoperative reformatted MR images with T2-weighted sequences in the same plane as the biopsy trajectory. Postoperative MRI showing the biopsy trajectory was manually merged to verify the accuracy of image superimposition. The methodology is detailed in [14] .
For each BS, the position in space with respect to the MRI-defined abnormalities with T2-weighted sequence was measured (Figure 1) . A number was assigned to each BS, indicating its position relative to the limits of MRI-defined abnormalities along the biopsy trajectory:
zero if the BS was on the limit, a positive value equal to the distance to the limit if the BS was outside MRI-defined abnormalities, and a negative value equal to the opposite of the distance to the limit if the BS was inside MRI-defined abnormalities ( Figure 1 ). The uncertainty (error bar) on the position of each BS, which results from the uncertainty on the position of the whole biopsy trajectory, was estimated to be between 4 and 8 mm. This uncertainty results from the actual peroperative position of the whole biopsy trajectory, which could be 2 mm higher or lower than represented on the MRI slice.
Cell count
For each BS, cell count analyses were restricted to regions of infiltrated white matter (exclusion of red blood cells and endothelial cells). Only the green component of the picture, with the highest contrast between cells and tissue, was kept. The threshold was chosen so as to select only the cell nuclei. Each BS was divided into four comparable regions, and the cell concentration in each region was computed as the number of cells divided by the surface area.
The mean cell concentration was calculated as the mean over the four regions. The error bars on the cell concentration represent the maximum and the minimum cell concentration among the four studied regions.
Edema quantification
To quantify the edema, we developed a new method based on the color analysis of pictures of digitized BSs.
Using the RGB model, a triplet of relative intensity levels of red, green, and blue (R,G,B)
characterizes any color, each component intensity being coded on 256 intensity levels. The color "white" corresponds to the triplet (255, 255, 255) and the color "black" corresponds to (0,0,0).
Each pixel has its own color and its own triplet (R,G,B). The three-color histograms of pictures of digitized slices of BSs were obtained using the ImageJ plugin "Color Histogram".
We considered that the slices were two-dimensional, since they were not thicker than a cell diameter. Images did not display a uniform color, so the color histograms, representing the distributions of levels of (R,G,B) over all the pixels of the picture, were broad ( Figure 3 ). To characterize the tissue, we used the mean values of these distributions, and we referred to 
The quantities given patient is close to the function: x=1−10
Since pathological samples were prepared using the same routines, we assumed that all the BSs for one patient were colored the same way, so that the difference of coloration between the BSs were only due to different amounts of edema. Each BS was divided into four regions, and the color histograms of each region were extracted. The most distant BS from MRI-defined abnormalities was considered as "normal" by the pathologists, with an edema fraction equal to zero (sample P1 in Figure 1 ), and the means of the green and the red histograms were used to calculate R−G. For the other
BSs Pi with i > 1, the edema fraction was obtained with the formula:
In order to estimate the error due to the variation of staining from sample to sample, we prepared new slices from the BSs of a patient (patient 6). We found that the variation of the estimated fraction of edema does not exceed 6% between the old slices and the new ones (supplementary figure).
As explained above, the error bars on the edema fraction represented the maximum and the minimum edema fraction among the four studied regions (intra-sample variability). However, to also take into account the sample-to-sample variability estimated around 6%, we fixed the minimum length of the error bars to +/-6%.
Statistical analysis
Descriptive results are presented as mean ± standard deviation (range). Analyses were carried out using the unpaired t-test or Mann-Whitney rank-sum test for continuous variables, as appropriate. A P-value of less than 0.05 was considered to be significant. All statistical analyses were performed using JMP, version 10.0.0 (SAS institute, Cary, NC, USA). For linear regressions, the coefficient of determination was calculated.
Results
Edema fraction
For all patients, the mean edema fraction of each BS was plotted as a function of the position of the BS along the axis of the biopsy trajectory ( Figure 4 ). The edema fraction was significantly higher in BSs located inside (mean 45 ± 23 %, range 11.1-88.0 %) compared to outside (mean 5 ± 9 %, range 0-33 %) MRI-defined abnormalities (p<0.0001). For all patients, the edema fraction was equal to zero in the BS situated at the greatest distance from the MRI-defined abnormalities. Although maximum edema fractions inside imaging abnormalities varied from one patient to one another, the edema fraction at the limit of the signal abnormalities on T2-weighted sequence (obtained by linear interpolation between two data points inside and outside MRI-defined abnormalities) corresponded to a common value of 20%.
Cell concentration
For all patients, the mean cell concentration of each BS was plotted as a function of the position of the BS along the axis of the biopsy trajectory ( Figure 5 ).
In all but two patients (patients 1 and 6), the cell concentration increased from outside to inside MRI-defined abnormalities with a significantly higher cell concentration in BSs located inside (1189 ± 378; range 447-1900 cell/mm 2 ) compared to outside (740 ± 124; range 532-938 cell/ mm 2 ) MRI-defined abnormalities (p=0.0003). The mean value of the cell concentration at the limit of MRI-defined abnormalities (obtained by linear interpolation between two data points inside and outside MRI-defined abnormalities) was 981 ± 218 cell/mm 2 (range 750-1350 cell/mm 2 ). We assumed the "normal" cell concentration in the white matter (756 ± 111; range 577-893 cell/mm 2 ) as the cell concentration at the greatest distance from MRI-defined abnormalities. We assumed that the increase of cell concentration was due only to tumor cells, and we deduced the mean tumor cell concentration by subtracting the mean "normal" cell concentration. We obtained a mean tumor cell concentration at the limit of MRI-defined abnormalities of 225 ± 244 cell/mm 2 (range 0-600 cell/mm 2 ). The imaging signal changes did not seem to correspond to a unique cell concentration threshold (and unlikely to a tumor cell concentration threshold) among all patients, because the dispersion of the cell concentration at the limit of MRI-defined abnormalities was large.
We performed additional IDH1 immunostainings to identify mutated tumor cells in 3 BSs of patient 2 [28] . Since the cytoplasm of the cells was stained, we were able to estimate the tumor cell section area. We measured a maximum tumor cell section area of 206 µm good agreement with the cell concentration calculated in Figure 5 , top right.
Cycling cell concentration
For all patients, the mean cycling cell concentration of each BS was plotted as a function of the position of the BS along the axis of the biopsy trajectory ( Figure 6 , top left). The cycling cell concentration increased from outside to inside MRI-defined abnormalities, with a significantly higher cycling cell concentration in BSs located inside (10 ± 12; range, 0-41.3 cell/mm 2 ) compared to outside (0.5 ± 0.9; range, 0-3.9 cell/mm 2 ) MRI-defined abnormalities (p=0.0001). The corrected cycling cell concentration (where the surface area of edema was deduced from the total surface area of the tissue) also increased from outside to inside MRIdefined abnormalities with a significantly higher corrected cycling cell concentration in BSs located inside (32 ± 58; range, 0-230 cell/mm 2 ) compared to outside (0.6 ± 1.0; range, 0-3.9
cell/mm 2 ) MRI-defined abnormalities (p<0.0001) ( Figure 6 , top right). We assumed that the increase in the cycling cells concentration was due only to the presence of tumor cells. We justify this assumption by the fact that it has been shown in [14] that MIB1-positive cells in these patients coexpressed OLIG2, and thus belong to the oligodendroglial lineage (which exclude reactive astrocytes or activated microglia). In the normal adult brain there exists a population of cycling cells (belonging to the oligodendroglial lineage) scattered throughout the cortex and the white matter [29] , but their concentration is so low (the maximum is 0.4 cell/mm 2 , or 0.05% of the total cell number) than it can be neglected compared to the cycling cell concentrations measured in the tumors.
Consequently, cycling tumor cells infiltrating the parenchyma around the tumor core were found up to 20 mm outside the MRI-defined abnormalities in accordance with previous reports [11, 13, 14] . We estimated the total tumor cell concentration (cycling and non-cycling tumor cells) by subtracting the normal cell concentration (measured in regions far from MRIdefined abnormalities) from the total cell concentration (corrected by edema) while assuming that normal cells did not die and did not proliferate inside the tumor core. We were able to calculate the cycling tumor cell concentration for Patient 1 at only one location (-16.4mm) since the sample at -5.7mm did not display any significant increase in the cell concentration compared to the normal tissue. Since one point is not sufficient to see a trend, we excluded this patient (but only from the cycling tumor cell study).
The cycling tumor cell fraction (defined as the ratio of the cycling tumor cell concentration to the total number of tumor cells) was significantly higher in BSs located inside (2 ± 2.6 %; range, 0-10 %) than outside (0.2 ± 0.3 %, range, 0-0.8 %) MRI-defined abnormalities (p=0.015) (Figure 6 , bottom).
The eight remaining patients were divided into two groups: in 62.5% of cases (patients 2, 3, 4, 
Discussion
In the present work, we quantified the edema fraction, the cell concentration and the cycling cell concentration both inside and outside MRI-defined abnormalities with T2-weighted sequence in adults that underwent MRI-based serial stereotactic biopsies for the diagnosis of untreated supratentorial diffuse low-grade oligodendrogliomas. We found that: 1) MRIdefined abnormalities with T2-weighted sequence were mainly correlated with the edema fraction but not with the total cell concentration, the tumor cell concentration, or to the cycling cell concentration; 2) the limits of the imaging abnormalities corresponded to a common threshold of 20% of edema fraction; and 3) the cycling cells formed a ring of proliferation at the DLGG borders, i.e., at the inner limits of the imaging abnormalities. In addition, we provided a new method to quantify edema on histological samples.
In the case of DLGG, we propose that edema results from alterations of the extracellular matrix due to the presence of infiltrative tumor cells, since we showed that the edema fraction was correlated to the corrected tumor cell concentration. Vacuoles of various sizes form between fibers [30, 31] . Since the blood-brain barrier is morphologically and radiologically intact in DLGG, the interstitial edema is more likely due to an alteration of the osmotic gradient between plasma and interstitial fluid [7] . Nevertheless, the mechanisms underlying inducing aquaporin 4 expression leading to modification of water and electrolytes transcapillar exchanges and of ion homeostasis ( [33] , [34] , [35] ). All these modifications are thus more related to a cytotoxic than vasogenic general mechanisms. However, a recent study, based on a recent real-time in vivo imaging technique, showed that single isolated glioma cells were able to induce vascular remodeling and intussusceptive microvascular growth [36] .
This study, revealing discrete peritumoral angiogenesis, suggests that in "pre-contrast enhancing" regions, tiny vascular changes could explain glioma-related brain edema.
Our results are in agreement with a previous report showing that the hyperintense region with T2-weighted sequence contained more water than normal tissue [31] . This study also reports a close visual correlation between peritumoral hyperintensity with T2-weighted sequence and areas of pallor on the hematoxylin-eosin stained whole-brain sections, but no quantitative measurements were performed.
We developed an original method of edema quantification. Its main advantage is that it does not involve any threshold, thus improving reproducibility. The main drawback is the assumption that the observed color changes are only due to the presence of edema, since the slice thickness and the coloration techniques were constant in all the BSs of a given patient.
The cycling tumor cell fraction varies within the tumor, with a maximal cycling tumor cell concentration at the inner limits of the MRI-defined abnormalities in 62.5% of cases and at the center of the tumor in 37.5% of cases. As a practical consequence, pathologists should pay particular attention to both the center and the peripheral regions of a DLGG to accurately estimate proliferation rates. In addition, since DLGG are infiltrative tumors made of isolated tumor cells that permeate the brain parenchyma, the proliferation rates should ideally be estimated by the ratio between cycling cells and tumor cells and not between cycling cells and the whole cell population, because the presence of numerous non-tumor cells may lead to underestimate the actual proliferation rates.
The finding that cycling cells form a ring of proliferation at the tumor peripheral areas recalls a previous study in which a maximum of metabolism was detected in BSs performed in the periphery of DLGG as compared to those performed in the tumor center [37] . The diffusionproliferation model for diffuse gliomas [19, 22, 23] has also predicted a saturation phenomenon in the interior of some tumors: the cell proliferation decreases in regions with high cell concentration and is absent when the cell concentration is maximal. The evidence that such a saturation phenomenon occurs for some patients would mean that the cell concentration, even in some DLGG, is high enough to slow down the proliferation rate of tumor cells. In DLGG, this saturation phenomenon was unexpected, since these tumors do not These results should help to conceive new models based on the findings that: 1) edema is more related to the imaging abnormalities than to cell concentration; 2) edema is correlated with tumor cell concentration. In addition, they may help to validate existing models if observed and predicted cell and cycling cell concentrations are compared. Tables:   Patient   number   1  2  3  4  5  6 The signal abnormality is defined as the region (containing the image center) where the gray level is equal to or larger than the gray level of the cortex. When the signal window changes, the contrast between white and gray matter also changes, but the measured diameter of the abnormality remains the same, 26.5 ± 1 pixels. Analyzing all samples, we find that for this patient, the amount of edema is given by the formula: x = 0.92(1.01 − 10
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. For this patient, we obtain 0% of edema for sample P1, 26% for P3 and 71% for P4. 
